Study on clinical efficacy of Compound Foercao Mixture in the treatment of acute exacerbation of chronic obstructive pulmonary disease with phlegm-heat stagnation lung syndrome and related risk factors of acute exacerbation of copd

Phase 1

Not yet recruiting

• Conditions: COPD

• Registration Number: ITMCTR2000003678
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Conform to the diagnostic criteria of Western medicine for acute exacerbation of chronic obstructive pulmonary disease;
2. Conform to the syndrome differentiation standard of TCM (phlegm-heat stagnation and lung syndrome);
3. Patients in group B and Group C were included in the comprehensive assessment of COPD;
4. Patients aged between 40 and 75;
5. Those who can accept the treatment of this protocol, cooperate with the completion of clinical observation, and voluntarily sign the informed consent;
6. Patients who had not used traditional Chinese medicine preparation for relieving cough and resolving phlegm within 48 hours before enrollment.

Exclusion Criteria

1. Patients with pneumonia, bronchial asthma, bronchiectasis, tuberculosis, lung cancer, interstitial lung disease or other lung diseases;
2. Patients with chronic obstructive pulmonary disease at stable stage;
3. Patients with severe primary diseases of cardiovascular and cerebrovascular, liver, kidney and hematopoietic system;
4. Pregnant and lactating women;
5. Allergic constitution or allergic to known ingredients of this drug;
6. Persons with mental or legal disabilities.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ung function;